122 related articles for article (PubMed ID: 7500065)
1. A strategy to arrest and reverse coronary artery disease: a 5-year longitudinal study of a single physician's practice.
Esselstyn CB; Ellis SG; Medendorp SV; Crowe TD
J Fam Pract; 1995 Dec; 41(6):560-8. PubMed ID: 7500065
[TBL] [Abstract][Full Text] [Related]
2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
4. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
5. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
6. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
Stone PH; Lloyd-Jones DM; Kinlay S; Frei B; Carlson W; Rubenstein J; Andrews TC; Johnstone M; Sopko G; Cole H; Orav J; Selwyn AP; Creager MA;
Circulation; 2005 Apr; 111(14):1747-55. PubMed ID: 15809368
[TBL] [Abstract][Full Text] [Related]
7. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
[TBL] [Abstract][Full Text] [Related]
8. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
9. Saturated fats, cholesterol, and dietary compliance.
Henkin Y; Garber DW; Osterlund LC; Darnell BE
Arch Intern Med; 1992 Jun; 152(6):1167-74. PubMed ID: 1599344
[TBL] [Abstract][Full Text] [Related]
10. Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia.
Bradley A; Elliott J; White H
N Z Med J; 1993 Jun; 106(958):243-7. PubMed ID: 8332291
[TBL] [Abstract][Full Text] [Related]
11. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
Nikkilä EA; Viikinkoski P; Valle M; Frick MH
Br Med J (Clin Res Ed); 1984 Jul; 289(6439):220-3. PubMed ID: 6430414
[TBL] [Abstract][Full Text] [Related]
12. [Low-fat diet and physical training in coronary heart disease. Long-term results of secondary prevention].
Niebauer J; Hambrecht R; Marburger C; Schlierf G; Kübler W; Schuler G
Dtsch Med Wochenschr; 1994 Jan; 119(1-2):7-12. PubMed ID: 8281886
[TBL] [Abstract][Full Text] [Related]
13. [The relationship between hyperfibrinogenemia and severity of coronary heart disease].
Liu MY; Hu DY; Yan L; Liu WH; Liu RH
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):820-3. PubMed ID: 15634539
[TBL] [Abstract][Full Text] [Related]
14. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
[TBL] [Abstract][Full Text] [Related]
15. Regression of severe atherosclerotic plaque in patients with mild elevation of LDL cholesterol.
Schaefer S; Hussein H; Gershony GR; Rutledge JC; Kappagoda CT
J Investig Med; 1997 Dec; 45(9):536-41. PubMed ID: 9444880
[TBL] [Abstract][Full Text] [Related]
16. Motivational effect of cholesterol measurement in general practice health checks.
Robertson I; Phillips A; Mant D; Thorogood M; Fowler G; Fuller A; Yudkin P; Woods M
Br J Gen Pract; 1992 Nov; 42(364):469-72. PubMed ID: 1472394
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes in serum cholesterol level does not influence the progression of coronary calcification.
Tenenbaum A; Shemesh J; Koren-Morag N; Fisman EZ; Adler Y; Goldenberg I; Tanne D; Hay I; Schwammenthal E; Motro M
Int J Cardiol; 2011 Jul; 150(2):130-4. PubMed ID: 20350769
[TBL] [Abstract][Full Text] [Related]
18. Treatment of coronary heart disease by diet and exercise: fasting and diurnal lipoproteins.
Schlierf G; Schuler G; Wirth A; Kohlmeier M; Vogel G
Klin Wochenschr; 1988 Nov; 66(22):1103-9. PubMed ID: 3236760
[TBL] [Abstract][Full Text] [Related]
19. Coronary risk factors in women six months after coronary artery bypass grafting.
Allen JK; Blumenthal RS
Am J Cardiol; 1995 Jun; 75(16):1092-5. PubMed ID: 7762491
[TBL] [Abstract][Full Text] [Related]
20. Five years of physical exercise and low fat diet: effects on progression of coronary artery disease.
Niebauer J; Hambrecht R; Schlierf G; Marburger C; Kälberer B; Kübler W; Schuler G
J Cardiopulm Rehabil; 1995; 15(1):47-64. PubMed ID: 8529087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
